Post-Transplant Diabetes Outcomes Prediction — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Post-Transplant Diabetes Outcomes Prediction — Stella

Home/New Onset Diabetes After Transplantation/

View on ClinicalTrials.gov

Recruiting

Back to New Onset Diabetes After Transplantation trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Italy

Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Nefrologia, Roma

Key details

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Enrollment target

~120 participants

Started

August 2024

Primary completion

February 2027

Age range

18 Years – 70 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.